NovoCure Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include Zymeworks.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Zymeworks
Zymeworks
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Founding Date
Founding Date
2018
Founding Date
2003
Type
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Locations
Vancouver, CA HQ
Seattle, US
Employees
Employees
188
Employees
45519% increase
Valuation ($)
Valuation ($)
243.3 m
Valuation ($)
973.3 m

Financial

Revenue (est.)
Revenue (est.)
$36k (FY, 2025)
Revenue (est.)
$106m (FY, 2025)
Net income
Net income
($274.4m) (FY, 2025)
Net income
($81.1m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Zymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.

View company